Our site uses cookies to make navigation as function as possible, including “third party” cookies and “profiling cookies” designed to tailor
on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your
consent to some or all cookies, click here. If you proceed with browsing this website, you will be consenting to the use of all cookies.

美纳里尼基金会

该基金会成立于 1976 年...

GO TO SITE

美纳里尼在亚太地区

搜索我们的公司

主要品牌

最新动态

November 13 2020

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Read More
July 23 2020

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

Read More
June 10 2020

Menarini Group Completes Acquisition of Stemline Therapeutics

Read More
June 04 2020

Menarini invests 150 million euros in a new pharmaceutical plant in Italy

Read More
June 04 2020

Tillotts制药公司和美纳里尼宣布安萨科®(Asacol®)400mg/800mg 获批进入中国

Read More